| Systematic (IUPAC) name | |
|---|---|
| 2-(5-fluoro-1H-indol-3-yl)-N,N-dimethylethanamine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 22120-36-1 |
| ATC code | ? |
| PubChem | CID 2762738 |
| ChemSpider | 2043436 |
| Chemical data | |
| Formula | C12H15FN2 |
| Mol. mass | 206.259 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
5-Fluoro-N,N-dimethyltryptamine (5-fluoro-DMT) is a tryptamine derivative related to compounds such as 5-bromo-DMT and 5-MeO-DMT. Fluorination of hallucinogenic tryptamines either reduces or has little effect on 5-HT2A/C receptor affinity or intrinsic activity, although 6-fluoro-DET is inactive as a hallucinogen despite acting as a 5-HT2A agonist (cf. lisuride), while 4-fluoro-5-methoxy-DMT is a much stronger agonist at 5-HT1A than 5-HT2A.[1][2]
|
|||||
| This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)